Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRAME family member 35, pseudogene (PRAMEF35P), is a non-functional genomic DNA sequence in humans classified as a pseudogene; it derives from the PRAME gene family but has lost its protein-coding ability due to mutations. Pseudogenes structurally resemble genes but do not generally give rise to functional proteins[2][5]. While some pseudogenes can be transcribed or have potential regulatory or evolutionary roles, PRAMEF35P does not have established biological or pathological relevance and is not a druggable or therapeutic target[2][5]. The PRAME family includes many protein-coding genes involved in immunity and cancer antigens, but pseudogenes like PRAMEF35P lack these functions. Pseudogenes can complicate genetic testing and evolutionary interpretation but are not typically considered in drug discovery or clinical targeting[5]. Specific functions or disease roles are not reported for PRAMEF35P as of current major genetic databases and knowledge[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRAME family member 35, pseudogene (PRAMEF35P).